Discounted Cash Flow
UWM Holdings Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | — | — | — | — | — |
| 2020 | $161.2m | $-5.8m | $-5.8m | -3.6% | $-0.12 |
| 2021 | $3.0b (1743.1%) | $98.4m (1795.2%) | $98.4m (1795.2%) | 3.3% (192.0%) | $0.98 (916.7%) |
| 2022 | $2.4b (-20.1%) | $41.7m (-57.6%) | $41.7m (-57.6%) | 1.8% (-47.0%) | $0.45 (-54.1%) |
| 2023 | $1.3b (-44.7%) | $-13.2m (-131.7%) | $-13.2m (-131.7%) | -1.0% (-157.4%) | $-0.14 (-131.1%) |
| 2024 | $2.2b (65.0%) | $14.4m (208.9%) | $-6.3b (-47375.1%) | 0.7% (166.0%) | $0.13 (192.9%) |
| 2025 | $3.2b (46.1%) | $27.4m (90.1%) | $-2.7b (56.7%) | 0.9% (30.1%) | $0.13 (0.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.